[Skip to Content]
[Skip to Content Landing]
May 13, 1974

Regulating New Drugs

Author Affiliations

Director, AMA Dept of Drugs Chicago

JAMA. 1974;228(7):910. doi:10.1001/jama.1974.03230320070049

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


It is a rare physician today who does not have some opinion about the Food and Drug Administration (FDA). Judged by the majority of comments received by the AMA Department of Drugs, that opnion is usually unfavorable. The FDA confirms that it is generally held in poor repute by most American physicians. Why? Vast numbers of practitioners are convinced that the FDA is interfering with medical practice. They take umbrage with FDA medical decisions and, even more basically, with the 1962 Amendments to the Food and Drug Act under which the FDA must operate. Thus, it is logical to ask whether the 1962 amendments have benefited the public and whether the FDA has been effective in implementing the law. This little paperback book helps provide a few answers.

Under the sponsorship of the University of Chicago's Center for Policy Study, a conference of specialists from universities, medical centers, pharmaceutical companies,